Bank of America’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-50,000
Closed -$755K 8411
2024
Q1
$755K Hold
50,000
﹤0.01% 5110
2023
Q4
$1.08M Buy
+50,000
New +$922K ﹤0.01% 4928
2022
Q4
Sell
-10,000
Closed -$254K 8433
2022
Q3
$254K Hold
10,000
﹤0.01% 5842
2022
Q2
$332K Hold
10,000
﹤0.01% 5731
2022
Q1
$721K Sell
10,000
-275,000
-96% -$19.8M ﹤0.01% 5526
2021
Q4
$26.2M Buy
285,000
+156,200
+121% +$18.7M ﹤0.01% 1965
2021
Q3
$16.3M Sell
128,800
-48,100
-27% -$7M ﹤0.01% 2351
2021
Q2
$29.4M Sell
176,900
-649,200
-79% -$105M ﹤0.01% 1795
2021
Q1
$150M Buy
826,100
+810,900
+5,335% +$188M 0.02% 696
2020
Q4
$3.04M Sell
15,200
-84,800
-85% -$17.2M ﹤0.01% 3584
2020
Q3
$21.9M Buy
+100,000
New +$21.2M ﹤0.01% 1625
2018
Q1
Sell
-1,100
Closed -$38K 7341
2017
Q4
$38K Buy
+1,100
New +$36.5K ﹤0.01% 6187

Other funds holding TDOC

Bank of America's TDOC Position: Q1 2026 in Review

Bank of America increased its Teladoc Health (TDOC) stake by 290% in Q1 2026, buying an estimated $6.65M and bringing the position to 1,595,219 shares worth $8.69M. The position accounts for ﹤0.01% of the portfolio, ranked #3076.

Bank of America first reported a position in TDOC in Q3 2015 and has held it in 43 quarters since. The position peaked at $504M in Q3 2020. 323 funds tracked by Wall St. Rank hold TDOC as of Q1 2026.

  • Bank of America held 1,595,219 shares of Teladoc Health worth $8.69M as of Q1 2026.
  • Bank of America bought 1,186,042 Teladoc Health shares in Q1 2026, an estimated $6.65M.
  • Teladoc Health made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #3076 holding.
  • Bank of America first reported a position in Teladoc Health in Q3 2015 and has held it in 43 quarters since.
  • Bank of America's Teladoc Health position peaked at $504M in Q3 2020.
  • 323 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.